The patented non-invasive RF technology of Wellcomet® is based on the latest scientific findings and represents a worldwide novel treatment method, that enables precise working in the boundary layer DERMIS-SUBKUTIS, which has so far received less scientific attention.
The focus of the RF treatments is especially placed on the stimulation of reactive dermal adipocytes(dWAT-dermal white adipose tissue).
ADIPOCYTE BOUNDARY LAYER - THE NEW TARGET
Ageing processes of the skin are basically connected with the reduction of fat deposits and changes in the local fibrosis of the tissue.
The adipocyte reduction takes place by reduction of individual adipocytes, cell death or by differentiation of these cells into other cells (e.g. fibroblasts). These processes are always associated with a local volume loss in the tissue.
With the modernSKIN AURA® device the direct focus is on the interaction of the dermal adipocytes located in the boundary layer with the structures of the dermis above.
The Goal:
to achieve a visible increase in tissue volume caused by an adequate and precise heating of the adipocytic tissue of the boundary layer through cell volume increase, cell number increase and new formation of fibrotic structures.
While the the main target in conventional RF procedures is neocollagenesis by selective heating or induced "micro-injuries" of the skin, the SKIN AURA® procedure focuses on the targeted stimulation of the dWAT cells of the fat tissue, with the aim:
• Hyperplasia
• Hypertrophy
• Modulation of the extracellular matrix by fibrosis